IDEXX Laboratories, Inc.
IDXX
Classificação em ações
#559
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing,... IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Preço da ação
$556.46
Última sincronização: 2026-10-20
Valor de mercado
$43.84B
Variação (1 dia)
0.12%
Variação (1 ano)
-12.66%
País
US
Negociar IDEXX Laboratories, Inc. (IDXX)
Categoria
Healthcare
Lucros da IDEXX Laboratories, Inc. (IDXX)
Lucros em Jun 2026 TTM: $1.42B
De acordo com os últimos relatórios financeiros da IDEXX Laboratories, Inc., os ganhos atuais da empresa são de $1.42B. Em 2024, a empresa teve ganhos de $1.11B, um aumento em relação a aos ganhos de 2023, que foram de $1.06B. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da IDEXX Laboratories, Inc. de 2000 a 2026
Lucros no final de cada ano
| Ano | Lucros | Alterar |
|---|---|---|
| 2026 (TTM) | $1.42B | 7.57% |
| 2025 | $1.32B | 19.31% |
| 2024 | $1.11B | 4.59% |
| 2023 | $1.06B | 23.40% |
| 2022 | $859.97M | -4.73% |
| 2021 | $902.65M | 36.36% |
| 2020 | $661.99M | 26.76% |
| 2019 | $522.22M | 14.09% |
| 2018 | $457.74M | 20.12% |
| 2017 | $381.06M | 18.40% |
| 2016 | $321.85M | 17.83% |
| 2015 | $273.14M | 10.78% |
| 2014 | $246.56M | -6.35% |
| 2013 | $263.26M | 1.01% |
| 2012 | $260.62M | 11.17% |
| 2011 | $234.42M | 15.98% |
| 2010 | $202.13M | 15.81% |
| 2009 | $174.54M | 2.56% |
| 2008 | $170.19M | 26.21% |
| 2007 | $134.84M | 3.13% |
| 2006 | $130.75M | 10.36% |
| 2005 | $118.47M | 6.63% |
| 2004 | $111.10M | 33.45% |
| 2003 | $83.25M | 21.06% |
| 2002 | $68.77M | 16.99% |
| 2001 | $58.78M | 0.92% |
| 2000 | $58.25M | 0.00% |
Lucros de empresas semelhantes ou concorrentes
| Empresa | Lucros | Diferença de Lucros | País |
|---|---|---|---|
| $7.61B | 434.18% |
US
|
|
| $4.76B | 234.31% |
US
|
|
| $-252.70M | -117.74% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 16.40% |
US
|
